Locations:
Search
Combination therapy improves outcomes, but lobular patients still do worse overall than ductal counterparts
Standard of care is linked to better outcomes, but disease recurrence and other risk factors often drive alternative approaches
Multidisciplinary teams bring pathological and clinical expertise
Genetic variants exist irrespective of family history or other contributing factors
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population
National Blood Clot Alliance collaborates with faith-based organizations on first-of-its-kind church bus tour
AI-driven tools can streamline enrollment and improve efficiency across clinical trials.
Real-world applications in clinical documentation and trial matching
Psychosocial oncology offers a path forward
A conversation with Marcelo Pasquini, MD
Advertisement
Advertisement